Invitae Corp
NYSE:NVTA
Invitae Corp
Cash & Cash Equivalents
Invitae Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Invitae Corp
NYSE:NVTA
|
Cash & Cash Equivalents
$158m
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Cash & Cash Equivalents
$380.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-9%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash & Cash Equivalents
$474m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
0%
|
CAGR 10-Years
13%
|
|
CVS Health Corp
NYSE:CVS
|
Cash & Cash Equivalents
$9.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Cigna Corp
NYSE:CI
|
Cash & Cash Equivalents
$7.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash & Cash Equivalents
$99.3m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-12%
|
See Also
What is Invitae Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
158m
USD
Based on the financial report for Sep 30, 2023, Invitae Corp's Cash & Cash Equivalents amounts to 158m USD.
What is Invitae Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
9%
Over the last year, the Cash & Cash Equivalents growth was -27%. The average annual Cash & Cash Equivalents growth rates for Invitae Corp have been 14% over the past three years , 9% over the past five years .